NovelStem International (NSTM) Return on Assets [ROA] (2011 - 2026)
NovelStem International (NSTM) recorded Return on Assets [ROA] of -378.37% in Q2 2026, down 2315.33 percentage points from 1936.95% a year earlier and down 4707.50 percentage points from the prior quarter.
Powered by 
Analysis
NovelStem International (NSTM) Return on Assets [ROA] (2011 - 2026) Analysis & Trends
For FY2025, NovelStem International reported Return on Assets [ROA] of 2699.09%, up 2818.64 percentage points from FY2024.
- Annual Return on Assets [ROA] has a four-year change of +2702.53 percentage points (FY2021 to FY2025).
- Across earlier years, Return on Assets [ROA] came in at -119.55% in FY2024 (+51.56 pp), -171.11% in FY2023 (-153.40 pp), -17.71% in FY2022 (-14.27 pp) and -3.44% in FY2021.
- The Q2 2026 figure is the lowest quarterly Return on Assets [ROA] since Q1 2025.
- On a year-over-year basis, Return on Assets [ROA] rose in two of the last four quarters, with an average year-over-year change of +4624.57 percentage points.
- Per Business Quant, the preceding three quarters came in at 4329.13% (Q1 2026), 15497.37% (Q4 2025) and 15270.86% (Q3 2025).
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | ROA (Qtr) |
|---|---|---|---|---|---|
| 1 | Eli Lilly | 1,076.25 Bn | 1,044.84 Bn | 19.71 Bn | 20.64% |
| 2 | Johnson & Johnson | 617.18 Bn | 535.70 Bn | 17.26 Bn | 10.47% |
| 3 | AbbVie | 464.58 Bn | 437.73 Bn | 12.70 Bn | 4.65% |
| 4 | Merck | 356.04 Bn | 310.47 Bn | 12.21 Bn | 2.45% |
| 5 | Novartis Ag | 269.07 Bn | 224.94 Bn | 11.24 Bn | 28.37% |
| 6 | Astrazeneca | 243.21 Bn | 216.77 Bn | 12.86 Bn | 9.10% |
| 7 | Amgen | 217.88 Bn | 173.28 Bn | 7.24 Bn | 9.29% |
| 8 | Gilead Sciences | 179.62 Bn | 153.74 Bn | 6.22 Bn | -6.13% |
| 9 | Pfizer | 158.45 Bn | 105.40 Bn | 10.94 Bn | 2.14% |
| 10 | NovelStem International | 493,324.54 | 346,279.54 | - | -378.37% |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | -378.37% |
| Mar 31, 2026 | 4,329.13% |
| Dec 31, 2025 | 15,497.37% |
| Sep 30, 2025 | 15,270.86% |
| Jun 30, 2025 | 1,936.95% |
| Mar 31, 2025 | -903.25% |
| Dec 31, 2024 | -805.00% |
| Mar 31, 2024 | -182.10% |
| Sep 30, 2023 | -201.46% |
| Jun 30, 2023 | -155.12% |
| Mar 31, 2023 | -34.53% |
| Dec 31, 2022 | -19.21% |
| Sep 30, 2022 | -17.56% |
| Sep 30, 2013 | 66.48% |
| Jun 30, 2013 | 43.21% |
| Mar 31, 2013 | 40.47% |
| Dec 31, 2012 | 50.35% |
| Sep 30, 2012 | -8.57% |
| Jun 30, 2012 | -36.97% |
| Mar 31, 2012 | -31.15% |
API Access
NovelStem International Return on Assets [ROA] API
Pull this series into your own models, spreadsheets and apps with the Business Quant
Historical Metrics API. The request below matches the chart above — change the
frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/historic?slug=return-on-assets-%5Broa%5D&ticker=NSTM&period=max&api_key=YOUR_API_KEYimport requests
url = "https://data.businessquant.com/historic"
params = {"slug": "return-on-assets-[roa]", "ticker": "NSTM", "period": "max", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()const res = await fetch("https://data.businessquant.com/historic?slug=return-on-assets-%5Broa%5D&ticker=NSTM&period=max&api_key=YOUR_API_KEY");
const data = await res.json();